Location: Home
  • search
  • go
  • Relate News
  • 3/18/2022Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021
  • 3/18/2022Recent Executive Moves
  • 3/16/2022Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo
  • 3/16/2022PharmCube: An Analysis of NDAs in China
  • 3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
  • 3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility
  • 3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines
  • 3/11/2022Recent Executive Moves
  • 3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
  • 3/10/2022SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...
  • 3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)
  • 3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha
  • 3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China
  • 3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
  • 3/7/2022Altamira and Nuance Enter Licensing and Distribution Deal for Bentrio ...
  • 3/7/2022Hutchmed Gets $15M from AstraZeneca as Part of Orpathys Drug Program i...
  • 3/7/2022NHSA Releases Its 2021 Healthcare Security Sector Development Statisti...
  • 3/7/2022NHC Establishes the Pharmacy Management and Drug Therapy Committee
  • 3/7/2022Central Government Report Emphasizes on Nine Healthcare Reform Measure...
  • 3/4/2022Recent Executive Moves
  • 3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
  • 3/3/2022Lesson from China's National Negotiation of Drug Prices in 2021 (NLR)
  • 3/2/2022FDA OKs J&J and Legend's BCMA CAR-T, Setting Stage for Showdown with B...
  • 3/1/2022Financial-related Company News Digest
  • 3/1/2022Digestome Therapeutics Licenses Schizophrenia Drug DGX-001 for Greater...
  • 2/28/2022Most MNCs and Domestics Face Serious Headwinds, But Some Managed to Ex...
  • 2/26/2022IQVIA: Chinese Hospital Drug Market Rose 2.2% in MAT Q4/2021
  • 2/23/2022Kiniksa Pharma and Huadong Medicine Announce Strategic Collaboration
  • 2/22/2022Stemirna gets ready for China's own mRNA Covid-19 vaccine as global mu...
  • 2/22/2022Eli Lilly Fared Well in China Last Year Despite Slowing Q4 Growth over...
  • Page:74/360 Total number of articles:10791: [First][<<] [72] [73] [74] [75] [76] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group